KERX +42.9% (forgot to put out alert yesterday) (announces Zerenex meets primary and all key secondary endpoints in Phase 3 long-term study as a treatment for Jyperphosphatemia; expects NDA with FDA in Q2 of 2013).
This stock has been on my trading list for a very long time, and is really paying off. Close Friday at $3.43. High pre-market price today is $5.25, testing the $5.42 high on 6-1-11. All technical's are on a buy signal as of 6 days ago when volume sky rocketed to the highest of the year. This is a message in increasing volume, and volume precedes price.
Market Data 
Markets 
AI
